Later, Guo et al. confirmed that downregulating SETDB1 enhanced ICB response in ovarian cancer, showing that SETDB1 repression activated interferon signaling through both cGAS‐STING and RNA sensing pathways.41 This evidence concerns the gene STING1 and ovarian carcinoma.